Liposomal Hemorrhoid Master

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Liposomal Hemorrhoid Master
Generic name: LIDOCAINE , PHENYLEPHRINE HCL
Manufacturer: Clinical Resolution Laboratory, Inc.
Product type: HUMAN OTC DRUG
SPL set ID: a1e15d2a-44b6-4d9c-89c2-0ff12285724e
SPL ID: 4c144a10-cfb2-662b-e063-6394a90a2d0f
Version: 2
Effective date: 2026-03-02
Source export date: 2026-09-28
Source partition: 6
Source file: https://download.open.fda.gov/drug/label/drug-label-0006-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/e0861bcde1444ef952820955caafc6f3fd29783e5ade07a13d933aa3336b399f/drug-label-0006-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:35:40

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 12 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M015	openfda.application_number
brand name		Liposomal Hemorrhoid Master	openfda.brand_name
generic name		LIDOCAINE , PHENYLEPHRINE HCL	openfda.generic_name
manufacturer name		Clinical Resolution Laboratory, Inc.	openfda.manufacturer_name
ndc	package	63742-038-01	openfda.package_ndc
ndc	product	63742-038	openfda.product_ndc
ndc11	package	63742003801	derived:openfda.package_ndc
rxcui		1314136	openfda.rxcui
spl id		4c144a10-cfb2-662b-e063-6394a90a2d0f	id
spl set id		a1e15d2a-44b6-4d9c-89c2-0ff12285724e	set_id
unii		98PI200987	openfda.unii
unii		04JA59TNSJ	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external and / or intrarectal use only. If condition worsens or does not improve within 7 days, consult a doctor. Do not exceed the recommended daily dosage unless directed by a doctor. In case of bleeding, consult a doctor promptly. Certain persons can develop allergic reactions to ingredients in this product. If the symptom being treated does not subside or if redness, irritation, swelling, pain, or other symptoms develop or increase, discontinue use and consult a doctor. Do not use this product if you have heart disease, high blood pressure, thyroid disease, diabetes or difficulty in urination due to enlargement of the prostate gland unless directed by a doctor. Ask a doctor or pharmacist before use if you are presently taking a prescription drug for high blood pressure or depression. Do not use this product with an applicator if the introduction of the applicator into the rectum causes additional pain. Consult a doctor promptly.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.